ACE2 and inflammatory bowel disease: In regard of the findings, that intestinal persistence of SARS-CoV2 might fuel the generation and maintenance of memory B cells,38 it is in our opinion even more difficult to interpret whether reduced intestinal ACE2 expression in IBD should be considered as a risk factor weakening anti-viral immune responses or as benefitial factor reducing the pool of SARS-CoV2.